![]() | ![]() |
![]() | ![]() | |
|
Company investors Market technology News Employment Contact |
Market Uterine Fibroids Fibroids -- also known as myomas or leiomyomas -- are extremely common benign tumors of the uterus which can substantially impact quality of life. Symptoms can include heavy or irregular menstrual bleeding, pelvic cramps, urinary frequency or urgency, and infertility or pregnancy loss. According to the U.S. Dept. of Health & Human Services, 25% of all women (16 million) suffer from fibroid symptoms, leading to 250,000 annual hysterectomies – a highly invasive surgery with many side effects. The problem is so widespread that a third of all U.S. women have undergone hysterectomy by age 60, with fibroids being the most common reason. ![]() Uterine anatomy ![]() Current Treatments Current fibroid therapies include:
Mirabilis will provide the first non-invasive solution for use by gynecologists. The company's system will be usable in a low-cost office setting, which benefits all stakeholders (patients, physicians, payers). Pain, side effects, and recovery (<1 day) will be substantially improved relative to invasive alternatives. | |
|
© 2008 MIRABILIS MEDICA | ||